Breast Ductal Carcinoma — Trials

Breast Ductal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

210 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 60
Recruiting: 32
Ph III recruiting: 3
Growth YoY: —
Industry share: 5%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 35.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (37)

clinicaltrialsPublishedShowing 51–59 of 59 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01372618	Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor	terminated	Phase 1 / Phase 2	9	NYU Langone HealthOTHER	1	Dec 27, 2017	clinicaltrials
NCT01754519	Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery	terminated	Phase 2	1	Roswell Park Cancer InstituteOTHER	1	Jul 7, 2017	clinicaltrials